The abstract is read at the publisher; the summary is JClub's.
In Novi Sad children aged 2–60 months (Oct 2022–Sep 2026), pneumococcal nasopharyngeal carriage prevalence was 27.0% (911/3,373), with diverse serotypes and notable antimicrobial resistance.
- Why it matters: Carriage in young children can precede pneumococcal disease, and vaccine-driven serotype shifts plus resistance changes require ongoing local surveillance to track coverage and replacement.
- What they did: A prospective outpatient surveillance study collected nasopharyngeal specimens from healthy children and those with acute respiratory tract infections, cultured S. pneumoniae, then performed serotyping and antimicrobial susceptibility testing on 1,312 isolates.
- The result: Theoretical vaccine serotype coverage was 8.2% (PCV10), 17.5% (PCV13), 20.0% (PCV15), and 47.3% (PCV20), with multidrug resistance in 18.1% of isolates and carriage linked to age, clinical status, season, and surveillance year.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.